GILEAD SCIENCES, INC.
GILD
67 insider filings · Latest: Oct 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Oct 16 8:17 PM | Andrew D DickinsonChief Financial Officer | Sale | 3,000 | $156.22 | $468.7K | 161,096(D) | View → |
| Oct 15, 2026 | Oct 16 8:12 PM | Johanna MercierChief Comm & Corp Aff Officer | Sale | 3,000 | $156.22 | $468.7K | 113,684(D) | View → |
| Oct 15, 2026 | Oct 15 8:22 PM | JOHANNA MERCIER | Proposed Sale | 3,000 | $156.22 | $468.7K | — | View → |
| Oct 15, 2026 | Oct 15 8:21 PM | ANDREW DICKINSON | Proposed Sale | 3,000 | $156.22 | $468.7K | — | View → |
| Oct 1, 2026 | Oct 2 8:40 PM | Daniel Patrick O'DayDirector, Chairman & CEO | Sale | 15,000 | $147.90 | $2.2M | 566,683(D) | View → |
| Sep 15, 2026 | Sep 16 8:30 PM | Andrew D DickinsonChief Financial Officer | Sale | 3,000 | $145.29 | $435.9K | 164,096(D) | View → |
| Sep 15, 2026 | Sep 16 8:27 PM | Johanna MercierChief Comm & Corp Aff Officer | Sale | 3,000 | $144.22 | $432.6K | 116,684(D) | View → |
| Sep 15, 2026 | Sep 15 8:20 PM | JOHANNA MERCIER | Proposed Sale | 3,000 | $144.22 | $432.6K | — | View → |
| Sep 15, 2026 | Sep 15 8:04 PM | ANDREW DICKINSON | Proposed Sale | 3,000 | $145.29 | $435.9K | — | View → |
| Sep 1, 2026 | Sep 2 8:12 PM | Daniel Patrick O'DayDirector, Chairman & CEO | Sale | 15,000 | $148.64 | $2.2M | 577,133(D) | View → |
| Aug 26, 2026 | Aug 27 10:44 PM | Anthony WeltersDirector | Sale | 18,000 | $148.62 | $2.7M | 12,894(D) | View → |
| Aug 26, 2026 | Aug 26 8:16 PM | ANTHONY WELTERS | Proposed Sale | 18,000 | $148.77 | $2.7M | — | View → |
| Aug 20, 2026 | Aug 21 11:22 PM | Jeffrey BluestoneDirector | Sale | 5,000 | $145.02 | $725.1K | 10,066(D) | View → |
| Aug 20, 2026 | Aug 20 8:36 PM | JEFFREY BLUESTONE | Proposed Sale | 5,000 | $147.60 | $738.0K | — | View → |
| Aug 17, 2026 | Aug 18 11:06 PM | Andrew D DickinsonChief Financial Officer | Sale | 3,000 | $138.36 | $415.1K | 165,646(D) | View → |
| Aug 17, 2026 | Aug 18 10:54 PM | Johanna MercierChief Comm & Corp Aff Officer | Sale | 28,000 | $137.64 | $3.9M | 118,234(D) | View → |
| Aug 17, 2026 | Aug 17 8:18 PM | JOHANNA MERCIER | Proposed Sale | 28,000 | $137.64 | $3.9M | — | View → |
| Aug 17, 2026 | Aug 17 8:11 PM | ANDREW DICKINSON | Proposed Sale | 3,000 | $138.36 | $415.1K | — | View → |
| Aug 3, 2026 | Aug 4 9:40 PM | Daniel Patrick O'DayDirector, Chairman & CEO | Sale | 15,000 | $130.31 | $2.0M | 592,133(D) | View → |
| Aug 3, 2026 | Aug 3 8:41 PM | DANIEL O'DAY | Proposed Sale | 55,000 | $130.21 | $7.2M | — | View → |
Page 1 of 6
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | May 4 8:25 PM | Javier RodriguezDirector | Grant/Award | 4,884 | $130.84 | 4,884(D) | View → |
| Apr 30, 2026 | May 4 8:22 PM | Anthony WeltersDirector | Grant/Award | 4,884 | $130.84 | 4,884(D) | View → |
| Apr 30, 2026 | May 4 8:20 PM | Harish ManwaniDirector | Grant/Award | 4,884 | $130.84 | 4,884(D) | View → |
| Apr 30, 2026 | May 4 8:19 PM | Kelly A. KramerDirector | Grant/Award | 6,030 | $130.84 | 4,884(D) | View → |
| Mar 10, 2026 | Mar 12 8:45 PM | Andrew D DickinsonChief Financial Officer | Grant/Award | 45,470 | $148.56 | 35,880(D) | View → |
| Mar 10, 2026 | Mar 12 8:45 PM | Andrew D DickinsonChief Financial Officer | Option Exercise | 6,469 | — | 21,057(D) | View → |
| Mar 10, 2026 | Mar 12 8:42 PM | Johanna MercierChief Comm & Corp Aff Officer | Grant/Award | 45,470 | $148.56 | 35,880(D) | View → |
| Mar 10, 2026 | Mar 12 8:42 PM | Johanna MercierChief Comm & Corp Aff Officer | Option Exercise | 6,617 | — | 21,057(D) | View → |
| Mar 10, 2026 | Mar 12 8:39 PM | Wettan Keeley M CainEVP Gen Counsel, Legal & Comp | Grant/Award | 23,935 | $148.56 | 18,885(D) | View → |
| Mar 10, 2026 | Mar 12 8:39 PM | Wettan Keeley M CainEVP Gen Counsel, Legal & Comp | Option Exercise | 1,246 | — | 15,536(D) | View → |
| Mar 10, 2026 | Mar 12 8:37 PM | Erin BurkhartSVP, Controllership | Grant/Award | 7,810 | $148.56 | 5,455(D) | View → |
| Mar 10, 2026 | Mar 12 8:24 PM | Daniel Patrick O'DayDirector, Chairman & CEO | Option Exercise | 20,026 | — | 68,044(D) | View → |
| Mar 10, 2026 | Mar 12 8:24 PM | Daniel Patrick O'DayDirector, Chairman & CEO | Grant/Award | 155,570 | $148.56 | 122,755(D) | View → |
| Mar 10, 2026 | Mar 12 8:22 PM | Dietmar BergerChief Medical Officer | Grant/Award | 39,890 | $148.56 | 31,475(D) | View → |
| Mar 10, 2026 | Mar 12 8:22 PM | Dietmar BergerChief Medical Officer | Option Exercise | 2,133 | — | 39,046(D) | View → |
| Feb 17, 2026 | Feb 18 10:22 PM | Johanna MercierChief Comm & Corp Aff Officer | Option Exercise | 25,000 | $66.64 | 48,110(D) | View → |
| Feb 5, 2026 | Feb 6 9:22 PM | Daniel Patrick O'DayDirector, Chairman & CEO | Option Exercise | 115,640 | $66.01 | 0(D) | View → |
| Jan 23, 2026 | Jan 27 12:29 AM | Daniel Patrick O'DayDirector, Chairman & CEO | Option Exercise | 115,640 | $66.01 | 115,640(D) | View → |
| Jan 20, 2026 | Jan 21 9:26 PM | Jeffrey BluestoneDirector | Option Exercise | 5,000 | $67.45 | 4,665(D) | View → |
← Previous
Page 2 of 2